Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Roche silently whisks away its $1.7B Seragon drug in a Q1 footnote
Roche silently whisks away its $1.7B Seragon drug in a Q1 footnote
Roche silently whisks away its $1.7B Seragon drug in a Q1 footnote
Submitted by
admin
on April 27, 2017 - 9:25am
Source:
Endpoints
News Tags:
Roche
Seragon
earnings
breast cancer
Headline:
Roche silently whisks away its $1.7B Seragon drug in a Q1 footnote
Do Not Allow Advertisers to Use My Personal information
